Why this drug needs an admission
Most cardiac medications can be started safely at home. Tikosyn (dofetilide) cannot.
Tikosyn’s job is to prolong the heart’s electrical recovery time after each beat — the QT interval — which makes it much harder for AFib or atrial flutter circuits to sustain themselves. The same effect, taken too far, can trigger a dangerous ventricular rhythm called torsades de pointes. The therapeutic window between “works well” and “too much” is narrow, and it is highly individual: kidney function, body size, electrolytes, other medications, and genetics all matter.
The FDA mandates a 72-hour inpatient initiation precisely because we cannot reliably predict who will tolerate the drug and who will not. We watch the ECG before every dose — and adjust or stop the drug at the first sign of trouble.
Before the admission
The pre-admission visit takes care of:
- A 12-lead ECG to establish a baseline QT interval. If your QT is already too long (above about 440 ms in men, 460 ms in women), Tikosyn is generally not safe to start.
- A check of your kidney function (creatinine clearance). Tikosyn is cleared by the kidneys, and the starting dose is based on how well your kidneys work. Patients with very poor kidney function cannot take it.
- A review of every medication you’re on, including over-the-counter products and supplements. A long list of medications interact with Tikosyn — particularly some antibiotics, antifungals, antidepressants, and antiacids — and several are absolute contraindications.
- An echocardiogram if you don’t have a recent one on file.
- Labs — kidney function, magnesium, and potassium. Low magnesium or potassium prolongs the QT and must be corrected before starting.
- A discussion of stopping other antiarrhythmics. Many patients are weaned off prior medications (amiodarone, sotalol, flecainide) for a window before Tikosyn starts.
- Scheduling. Most patients are admitted on a weekday morning and discharged on Wednesday or Thursday after the sixth dose is well tolerated.
What to bring
- Comfortable clothes and slip-on shoes — you can wear your own clothes on most monitored units.
- A book, tablet, charger, and headphones. The hours between ECGs are slow.
- Your medication list. The hospital pharmacy will resupply your usual medications, but they’ll want the list.
- A small toiletry bag.
- Your insurance card and ID.
- A driver for the day of discharge. You may feel fine; this is still an inpatient admission and we don’t recommend driving home solo.
During the admission
The schedule looks like this for most patients:
Day 1 (admission day)
- Morning: Check in, IV placed, baseline ECG repeated, baseline labs drawn.
- First dose of Tikosyn given typically around 8 AM (or whatever time the cardiology team picks).
- ECG at 2–3 hours after the dose. This is the most important measurement. The QT is checked. If the QT has lengthened too much, the dose for the next administration is reduced by half. If it has not lengthened enough, the dose continues.
- Second dose of Tikosyn given roughly 12 hours after the first.
- ECG 2–3 hours after the second dose. Same evaluation.
Day 2
- Third and fourth doses, with ECGs at the same 2–3 hour mark after each.
- Labs may be rechecked if electrolytes are drifting.
- The dose is considered “stable” once you’ve completed five doses without a QT problem.
Day 3
- Fifth and sixth doses.
- Final ECG to confirm the QT is stable on the chosen dose.
- Discharge the afternoon of Day 3 in most patients, occasionally Day 4.
You will be on continuous cardiac telemetry the entire admission. Each ECG is read by the team and discussed with the cardiologist or EP physician.
Common reasons we adjust or stop the drug
- QT lengthens too much (>500 ms or >15% increase from baseline) — the dose is reduced by half, or stopped if the lower dose still pushes the QT.
- A run of ventricular ectopy or non-sustained VT — this is taken seriously; the drug is usually stopped.
- Low potassium or magnesium that won’t correct — replaced aggressively, then the drug may continue.
- Symptoms — palpitations that feel different from your usual AFib, dizziness, fainting, fast heart rate during sleep.
About a quarter of patients have a dose reduction during their admission. About 5–10% have to stop entirely because the drug isn’t safe for them. We’d much rather catch this in the hospital than at home.
After discharge
You leave with:
- A specific Tikosyn dose (typically 125, 250, or 500 micrograms twice daily based on kidney function and QT response)
- A medication card confirming you completed an FDA-mandated loading
- Discharge instructions including the long list of drug interactions
- A follow-up plan: a clinic visit in 1–2 weeks, an ECG and labs at 3 months, and ongoing rhythm monitoring (wearable or device check) per your situation
Day-to-day on Tikosyn after the loading
- Take it exactly twice a day, about 12 hours apart. Missing a dose is fine; doubling up the next dose is not.
- Check with us before any new medication. Even routine antibiotics, antifungals, and over-the-counter products can interact dangerously. Pharmacists are usually careful but not always.
- Don’t suddenly stop. Talk to us first.
- Stay hydrated. Severe dehydration and electrolyte disturbances can swing the QT.
- Avoid potassium supplements unless we’ve prescribed them.
- Mind your other meds — some heart medications (amiodarone, certain calcium channel blockers, certain antidepressants) interact strongly.
If something keeps it from working — recurrent AFib, intolerable side effects, an interacting medication you can’t avoid — we have alternative paths. Tikosyn is not the only option; it’s one of several.
When to call us
After discharge, call right away for:
- Palpitations that feel different from your usual AFib — particularly fast, irregular, and accompanied by dizziness
- Fainting or near-fainting
- New chest pain or shortness of breath
- A new prescription or over-the-counter medication that you have not cleared with us yet
- Severe vomiting or diarrhea that may drop your potassium
In an emergency — sustained fast heart rate, fainting, chest pain — go to the nearest emergency room and tell the team you take Tikosyn. They will need to know.
Common questions
Why three days? Most patients reach steady-state drug levels after about five half-lives — for dofetilide, that’s roughly 2–3 days. Six doses give us a good look at how the drug behaves at steady state.
Will I sleep at the hospital? Yes, you’ll be in a regular hospital bed on a monitored unit. The biggest sleep disruption is the timing of the ECGs — particularly the 2 AM dose check on the second night. Bring earplugs and a sleep mask if you’re a light sleeper.
Can family visit? Yes. Standard hospital visiting hours apply.
Will I still have AFib episodes during the admission? Sometimes. The drug builds up over the three days. Many patients have a breakthrough episode that’s shorter and less symptomatic than before — others convert to normal rhythm during the admission itself.
What if I’m in AFib when I’m admitted? That’s actually preferable — we get to watch whether the drug converts you back to sinus rhythm during the admission.
Is this really worth it? For many patients, yes. Tikosyn is a powerful rhythm-control option for patients who can’t take other antiarrhythmics, who have heart failure (where amiodarone has long-term toxicity concerns), or who have failed prior options. The inpatient initiation is a one-time inconvenience for what is often years of better rhythm control.